HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of thymic carcinoma responded to intra-arterial chemotherapy combined with radiation therapy].

Abstract
A 70-year-old male complained of pain in the left neck. A tumor of about 8 cm in diameter was detected by contrast CT in the region extending from the anterior to upper mediastinum. For definitive diagnosis, biopsy was performed under CT guidance, and the patient was diagnosed as having anaplastic carcinoma in the thymus (T4, N1, M0, stage IVb). Since surgical treatment was judged to be impossible because of infiltration into large blood vessels, the patient underwent chemotherapy by intra-arterial injection (CDDP, ADM) and radiotherapy (45 Gy), and obtained a CR. Metastasis to the spleen was detected during the follow-up period, but a CR was obtained by chemotherapy by intra-arterial injection (CDDP) and systemic chemotherapy (TXL). Generally, the prognosis for carcinoma in the thymus is poor, and the prognosis for anaplastic carcinoma in the thymus is considered especially poor. However, chemotherapy by intra-arterial injection of carcinostatics such as CDDP can be applied to patients in whom surgical treatment is impossible.
AuthorsAkira Yamamoto, Shigeki Imai, Masayuki Gyoten, Yasumasa Kajihara
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 29 Issue 11 Pg. 1967-70 (Nov 2002) ISSN: 0385-0684 [Print] Japan
PMID12465397 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Doxorubicin
  • Cisplatin
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma (drug therapy, radiotherapy)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Doxorubicin (administration & dosage)
  • Humans
  • Injections, Intra-Arterial
  • Male
  • Radiotherapy Dosage
  • Thymus Neoplasms (drug therapy, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: